Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

US Patent 11459388 · Granted Oct 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD47 targeted therapies for the treatment of infectious disease2025
CD47 targeted therapies for the treatment of infectious disease2025
Interleukin-18 variants and methods of use2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Interleukin-18 variants and methods of use2025
Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Engraftment of stem cells with a combination of an agent that targets stem cells2025
Engraftment of stem cells with a combination of an agent that targets stem cells2025
Engraftment of stem cells with a combination of an agent that targets stem cells2025